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Abstract
Background: The electronic medical record (EMR) contains a rich source of information that could be harnessed for
epidemic surveillance. We asked if structured EMR data could be coupled with computerized processing of free-text clinical
entries to enhance detection of acute respiratory infections (ARI).
Methodology: A manual review of EMR records related to 15,377 outpatient visits uncovered 280 reference cases of ARI. We
used logistic regression with backward elimination to determine which among candidate structured EMR parameters
(diagnostic codes, vital signs and orders for tests, imaging and medications) contributed to the detection of those reference
cases. We also developed a computerized free-text search to identify clinical notes documenting at least two non-negated
ARI symptoms. We then used heuristics to build case-detection algorithms that best combined the retained structured EMR
parameters with the results of the text analysis.
Principal Findings: An adjusted grouping of diagnostic codes identified reference ARI patients with a sensitivity of 79%, a
specificity of 96% and a positive predictive value (PPV) of 32%. Of the 21 additional structured clinical parameters
considered, two contributed significantly to ARI detection: new prescriptions for cough remedies and elevations in body
temperature to at least 38uC. Together with the diagnostic codes, these parameters increased detection sensitivity to 87%,
but specificity and PPV declined to 95% and 25%, respectively. Adding text analysis increased sensitivity to 99%, but PPV
dropped further to 14%. Algorithms that required satisfying both a query of structured EMR parameters as well as text
analysis disclosed PPVs of 52–68% and retained sensitivities of 69–73%.
Conclusion: Structured EMR parameters and free-text analyses can be combined into algorithms that can detect ARI cases
with new levels of sensitivity or precision. These results highlight potential paths by which repurposed EMR information
could facilitate the discovery of epidemics before they cause mass casualties.
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Introduction
As the outbreak of severe acute respiratory syndrome (SARS)[1]
and the continued threat of novel influenza strains that could
produce pandemics illustrate [2,3], human populations remain
vulnerable to epidemics of acute respiratory infections (ARI).
These outbreaks must be discovered as soon as possible if control
measures are to be implemented in time to curb morbidity,
mortality and socioeconomic disruptions [4].
The increasing availability of electronic health data offers the
opportunity to enhance public health surveillance for infectious
diseases, a process that has historically relied on slow and
incomplete paper-based reporting [5]. Early electronic surveil-
lance efforts have collected codified diagnoses, chief complaints,
school absenteeism, over-the-counter medication sales and other
independent data streams to detect the early stages of infectious
illnesses, when mild signs and symptoms may not alarm clinicians
[6,7,8,9,10,11]. While the utility of these pre-diagnostic, so-called
‘‘syndromic’’ surveillance systems (SSS) has thus far been less than
persuasive, there is now increasing evidence that the electronic
transfer of diagnostic test results can lead to more complete and
timely reporting of notifiable diseases to the public health
authorities [12,13,14]. These results encourage the continued
search for new approaches aimed at improving the timeliness and
usefulness of surveillance alerts.
By assembling a rich array of clinical data around individual
patients, a surveillance system rooted in the electronic medical
record (EMR) could provide early and nuanced illness detection
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challenges of protecting patient privacy, an EMR-based surveil-
lance system could also support the efficient flow of information
necessary to promptly investigate alerts and manage evolving
epidemics [15,16,17]. To gain insight into the potential of the
EMR as a pre-diagnostic surveillance tool, we asked how
information automatically retrieved from a comprehensive EMR
could be arranged to detect patients with symptoms suggestive of
ARI. More specifically, we hypothesized that structured and free-
text clinical entries into the Veterans Administration’s (VA)
comprehensive EMR could be automatically extracted, trans-
formed and combined to improve ARI detection compared to the
sole use of ICD-9 diagnostic codes, a common basic avenue to
electronic disease detection.
Results
Study Population
The Maryland (n=5,127) and the Utah (n=10,250) study
samples were representative of their respective outpatient
populations and included mostly male veterans. They differed in
racial composition: the Utah population was more than 90%
Caucasian, whereas almost half of the Maryland veterans were
African American (Table 1).
ARI Cases
Our review of the 15,377 sampled records identified a total of
280 ARI cases. ARI incidence during the 6-month study period
was lower at the UT site (1.3%) than at the MD site (2.8%). On
average, ARI cases were younger than the study population at
both sites, with patients over the age of 70 representing 46% of the
study sample but only 21% of ARI cases (Table 1). The
distribution of ARI cases across outpatient or telephone care
areas is shown in Table 2. Two-thirds of ARI cases were seen in
the emergency room or in the same-day/walk-in primary care
areas, where they made up ,8% of the visits. Comparatively, ARI
cases amounted to less than 1% of visits to routine care areas.
Cough was the most commonly documented symptom of ARI
(88% of cases), followed by fever/chills/night sweats (58%) and
sore throat (45%). Eight (8) percent of ARI patients were febrile at
the time of the encounter. Table 3 displays the frequency with
which these and other less common symptoms and signs occurred,
either alone or in selected combinations. Note that gastrointestinal
symptoms were common complaints, even though they were not
part of the ARI case definition.
ARI CDAs That Use Structured EMR Parameters
Six of the EMR parameters considered were either not found or
present in only one ARI patient, and did not contribute to ARI
detection at either site. These included orders of diagnostic tests
for influenza or for other respiratory tract pathogens, prescriptions
for antivirals, antidiarrheals or antiemetics, and orders for sinus x-
rays. The overall frequency at which other EMR parameters
occurred at both sites is shown in Table 4. Providers wrote
prescriptions aimed at relieving cough or cold symptoms in 65% of
ARI patients, and blood tests or imaging in 27%. Rates at which
CBC, chest imaging and blood cultures were obtained were low
(Table 4) but increased with the number of abnormal vital signs
(Fig. 1).
CDAs that did not include ICD-9 codes achieved a peak
sensitivity of 80% and specificity of 69%, and were not retained
(data not shown). Table 5 reports the composition and
performance of illustrative CDAs that used ICD-9 codes either
alone (CDAs 1-3) or a combination with other structured EMR
parameters (CDA 4-9). ICD-9-only CDAs used by the BioSense
(CDA 1) or the ESSENCE (CDA 2) SSS during our study period
could be improved by adding three ARI-compatible ICD-9 codes
(acute maxillary sinusitis (461.0), acute sinusitis NOS (461.9), and
bronchitis NOS (490)) to the ESSENCE code set. The resulting
ICD-9 code set, labeled ‘‘VA’’ (CDA 3), was used as a starting
Table 1. Patients demographics.
Maryland Site Utah Site
Category Sub-category
Patient Base
n=206,561
Study Sample
n=5,127
ARI Cases
n=142
Patient Base
n=47,257
Study Sample
n=10,250
ARI Cases
n=138
Age ,21 y 0.2 0 0 0.3 0 0
21–30 y 2.3 1.7 3.5 4.5 1.1 3.6
31–40 y 7.9 4.7 11.3 5.5 2.7 3.6
41–50 y 15.9 14.9 28.2 9.1 7.5 13
51–60 y 20.6 24.4 25.4 23.3 23.7 37
61–70 y 13.6 16.5 14.1 18.8 21.5 18.1
71–80 y 20.7 25.9 12.7 23.1 30.5 15.2
81–90 y 15.2 11.4 4.9 14.9 12.7 8.7
91–100 y 2.4 0.5 0 0.5 0.2 0.7
Sex Male 86 91 88.7 92 96.1 92
Female 14 9 11.3 8 3.9 8
Race White 56.2 52.3 49.5 93.4 93.8 90.1
African 42.8 46.4 50.5 1.6 1.1 0
Hispanic 0.5 0.7 0 3.4 3.5 4.6
Other 0.5 0.6 0 1.5 1.5 5.3
Numbers within column 3-8 represent the percentage of the base, study sample and ARI populations.
doi:10.1371/journal.pone.0013377.t001
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improve ARI case detection when added to the VA ICD-9 codes:
orders for cough remedies, CBC, gram stains of respiratory
secretions, blood cultures and a temperature $38uC. Of these, the
‘‘Temperature $38uC’’ and the ‘‘Cough Remedies’’ parameters
were significant at both study sites, whether used alone (CDAs 4
and 6) or together (CDA 8). In contrast, the blood culture
parameter alone (CDA 5) or the addition of CBC and gram stains
to other parameters (e.g. CDA 9) were significant at one site, but
not at the other.
ARI CDAs That Use Free-Text EMR Entries
The Text-only CDA was as sensitive as a CDA that best
combined ICD-9 codes with other structured clinical parameters
(Table 6, compare CDA 10 to CDA 8). The ‘‘VA ICD-9 codes’’,
‘‘Cough Remedies’’ and ‘‘Text’’ CDA components could be
coupled through an OR operand to bring sensitivities up from
88%(CDA 10) to97–99%(CDAs11and 12).Whilethismaximized
the estimated area under the ROC curve, gains in sensitivity were
accompanied by losses in specificity (from 93 to 89%, CDA 10 to
CDA 12). Because of the low incidence of ARI in this broad
outpatient population (an average of 1.8% during our 6-month
study period), these losses in specificity halved the positive predictive
value (PPV) that had originally been obtained with CDA that used
ICD-9 codes alone (Table 6, compare CDA 3 to CDA 12). We
could design CDAs with high PPV (47–60%) using only structured
EMR parameters, for example by requiring that both the ‘‘ICD-9
codes’’ and the ‘‘Temperature $38uC’’ parameters be satisfied
(CDA 13). However, the resulting CDAs exhibited low sensitivities
(e.g. 6%, CDA 13, and 38%, CDA 14). CDAs that had to satisfy
both a query of structured EMR parameters as well as the text
analysis exhibited similarly high PPVs (52–54%), but retained much
higher sensitivities (69%, CDA 15, and 73%, CDA 16).
Targeting ARI Patients With an Influenza-Like Illness (ILI)
The Centers of Disease Control and Prevention (CDC) defines
an influenza-like illness (ILI) as an acute febrile illness (temperature
of $37.8uC) accompanied by a cough and/or a sore throat. Thus
defined, patients with ILI represent a subset of our broad ARI
population. A Text-only CDA achieved a higher sensitivity for ILI
than its ICD-9-only counterpart (Table 7, 92%, CDA 18 vs. 79%,
CDA 17). Despite specificities of 91-96%, both detection
approaches yielded PPVs in the 2–3% range. As could be
expected, restricting cases retrieved through ICD-9 codes or text
analysis to those patients who also have a temperature of at least
37.8uC increased the PPV more than 10-fold (CDAs 19 and 20)
without decreasing sensitivity. Selecting febrile patients who also
satisfied the [ICD-9-OR-Text] clause (CDA 21) identified all ILI
cases and yet maintained a PPV of 34%. Alternatively, requiring
patients to simultaneously satisfy the ICD-9 codes, text and
temperature parameters maximized the PPV (68%) while keeping
sensitivity above 70% (CDA 22).
Discussion
In this work, we combined selected structured EMR entries with
a computerized analysis of free-text documentation to detect
Table 2. Location of care of ARI patients.
Location of Care
% of Total
Visits
% of Total
ARI Cases
% of Visits
with ARI
Emergency Room 12.9 58.6 8.3
Same-Day Appointments 2.1 8.6 7.5
Telephone Care 11.2 13.2 2.1
Routine (Primary Care) 63.7 18.6 0.5
Routine (Specialty Care) 9.3 1.1 0.2
doi:10.1371/journal.pone.0013377.t002
Table 3. Symptoms and signs in ARI patients.
Symptoms/Signs Cough
Fever or
Chills or
Night
Sweats
Sore
throat
% of Total
ARI Cases
% of Cases with the
Additional Symptom
Cough 88.2 57 42
Fever or Chills or Night
Sweats
58.2 86 26
Sore throat 44.6 82 34
Myalgia or Arthralgia 22.9 81 59 38
Headache 19.6 73 38 42
Chest Pain-Pleuritic 8.2 91 48 22
Gastrointestinal* 16.4 91 67 35
Shortness of Breath 12.9 92 81 17
Malaise/Fatigue 10.7 90 87 20
Chest Pain-Non Pleuritic 5.4 93 60 27
Lymph node enlargement 2.1 0 67 67
Neurological** 1.8 80 40 40
Skin Lesion or Rash 0.7 50 50 100
*: includes nausea, vomiting, diarrhea or abdominal pain.
**: includes neck stiffness, changes in mental status, photophobia, diplopia or
other visual changes.
Percent of ARI patient population (n=280, column 2) with selected symptoms
or signs (column 1). Columns 3-5 represent the percent of ARI patients with the
symptoms/signs shown in Column 1 who also have cough (column 3), fever/
chills/night sweats (column 4) or sore throat (column 5).
doi:10.1371/journal.pone.0013377.t003
Table 4. Incidence of orders and abnormal vital signs in ARI
patients.
Category Subcategory
% of ARI
Cases
Prescriptions Cough Remedies 42.9
Other Cold Remedies 17.5
Antibiotics 33.8
Test Orders CBC/Diff 13.7
Chest Imaging 10
Gram Stain 1.8
Blood Culture 1.8
Vital Signs Abnormalities Heart Rate $100 beats/min 13.6
Respiratory Rate $22 breaths/min 10
Temperature $38uC 8.2
Percent of ARI patients for who selected medications or tests were ordered, or
who had abnormal vital signs. CBC/Diff stands for complete blood count with
differential white blood cell count.
doi:10.1371/journal.pone.0013377.t004
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PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13377Figure 1. Relationship between medical orders and the number of abnormal vital signs. Frequency of ordering selected medications and
tests (y axis) in ARI patients with normal vital signs (white bar), or who have an increasing number of abnormal vital signs (one (light grey bar), two
(dark grey bar) or three (black bar). For each vital sign, ‘‘abnormal’’ was defined as follows: temperature $38uC, respiratory rate $22 breath per
minute, heart rate $100 beats per minute.
doi:10.1371/journal.pone.0013377.g001
Table 5. Detection performance of CDAs that target ARI.
Case-Detection Algorithm Number
Category Subcategory 123456789
CDA Component BioSense ICD-9 Codes N
Essence ICD-9 Codes N
VA ICD-9 Codes NNNNNNN
OR Temperature $38uC NN N
OR Blood Culture NN
OR Cough Remedies NNNN
OR CBC/Diff N
OR Gram stain N
Maryland Site Sensitivity 61 68 78 81 81 84 87 87 87
Specificity 94 97 96 96 95 95 94 94 93
Positive Predictive Value 23 37 36 35 33 31 30 30 27
Area under the ROC 78 83 87 89 88 90 91 91 90
Utah Site Sensitivity 64 74 80 80 80 85 85 86 87
Specificity 91 98 97 97 97 96 95 95 92
Positive Predictive Value 9 29 27 25 25 20 20 19 13
Area under the ROC 78 86 89 89 89 91 90 91 90
Composition (black dot indicates that the component is included in the CDA) of ARI CDAs that combine parameters derived from structured EMR entries. Statistical
performance can be compared at each study site.
doi:10.1371/journal.pone.0013377.t005
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ities up to 99%, or PPV up to 68%. The results support our
working hypothesis that judicious use of information contained in
the EMR can improve early disease detection compared to the
sole use of diagnostic codes, and raise the possibility that
harnessing the EMR as a data source may improve the overall
performance of automated outbreak detection systems.
Case definitions used for influenza surveillance vary widely [18],
reflecting both the variability of influenza’s clinical presentation and
differing views on what distinguishes an influenza-like illness from
other ARI [19,20]. Absent a standard, we crafted a case definition
that would identify a broad population of patients with ARI. Most
(78%) of our ARI patients had normal vital signs and thus probably
suffered from mild, uncomplicated ARI [21]. Nevertheless, two-
third of them felt ill enough to visit urgent or same-day care areas.
Thus, the majority of patients who satisfied our case definition were
seeking health services despite a mostly mild illness. These patients
lie at the crosshair of syndromic surveillance.
We used a manual abstraction of respiratory symptoms from the
EMR as a reference standard to uncover cases of ARI. This case-
finding method may have underestimated the absolute incidence
of ARI encounters, as busy providers may not document
symptoms that are impertinent to a focused outpatient visit.
Nevertheless, the abstraction, which was done on a large random
sample of records, relied on information committed to a real-world
EMR and thus represents a realistic benchmark against which to
compare the performance of ARI detection algorithms relative to
each other.
Contribution of Diagnostic Codes
The reference review allowed an evaluation of a stalwart
component of SSS, ICD-9 diagnostic codes. Our data support the
suggestion that an early step toward system enhancement is to
scrutinize the ICD-9 codes used to categorize cases [22]: additions
of only a few codes improved both detection sensitivity and
specificity. While our observed level of performance may not be
duplicated in health systems where diagnostic codes are assigned
by non-providers and/or have reimbursement repercussions, our
findings reinforce results obtained in adult and pediatric
emergency room populations [23,24]. Note that the ICD-9 code
parameter was retained statistically in all of the most successful
ARI and ILI detectors, suggesting that diagnostic codes are not
made redundant with the availability of a broad array of
structured EMR parameters. Our results therefore suggest that
ICD-9 codes represent a valuable, perhaps indispensible compo-
nent of automated ARI detection algorithms, and bolster their
widespread use.
Table 6. Contribution of free-text analysis to ARI detection.
Case-Detection Algorithm Number
Category Subcategory 3 4 6 8 10* 11 12 13 14 15 16
CDA Component (VA ICD-9 Codes NNNN NNNNNN
OR Temperature $38uC NN
OR Cough Remedies NN N N
Text-Only; OR Text) NNN
AND Temperature .38uC N
AND Cough Remedies N
AND Text NN
Performance Sensitivity 79 80.5 84.5 86.5 88* 97 99 6 38 69 73
Specificity 96.5 96.5 95.5 94.5 93 90 89 99.9 99.9 99.9 99.9
Positive Predictive Value 31.5 30 25.5 24.5 18* 16 14 60 47 54 52
Area under the ROC 88 89 90 90 90 94 94 53 68 84 86
*Performance of text-mining routines is usually reported using the term ‘‘Recall’’ instead of ‘‘Sensitivity’’ and ‘‘Precision’’ instead of ‘‘Positive Predictive Value’’. Another
common text-mining metric, the F-measure (2 * Precision * Recall/(Precision + Recall) is 29.9 for CDA #10.
Composition (black dot indicates that the component is included in the CDA) of ARI CDAs that combine parameters derived from structured and free-text EMR entries.
Statistical performance was combined for both study sites. CDAs 3-12 seek increasing sensitivity; CDA 13-16 seek increasing PPV.
doi:10.1371/journal.pone.0013377.t006
Table 7. Performance of EMR-based CDA that target
influenza-like illness.
CDA Number
Category Subcategory 17 18 19 20 21 22
CDA Component (VA ICD-9 Codes NN N N
Text-Only; OR Text) NN N
AND Text N
AND Temperature
.37.8uC NNNN
Performance Sensitivity 79 92 75 92 100 71
Specificity 95.5 91 99.8 99.7 99.7 99.9
Positive Predictive Value 2.7 2 36.7 34 34 68
Area under the ROC 87 91 87 96 100 85
Composition (black dot indicates that the component is included in the CDA) of
ILI CDAs that combine parameters derived from structured and free-text EMR
entries. Statistical performance was combined for both study sites.
doi:10.1371/journal.pone.0013377.t007
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Diagnostic Codes
Some of the non-ICD-9 parameters considered in this study had
previously emerged as potentially useful for ARI surveillance. In
particular, sales of selected over-the-counter or prescription
medications [25,26,27,28,29,30,31,32] and requests for diagnostic
tests for influenza or for other respiratory pathogens [12,33] have
been shown to correlate with the seasonality of influenza and
respiratory syncytial virus infections. Our study revisits similar
parameters, adds new ones not yet formally investigated, but
evaluates them in a different way i.e. for the accuracy with which
they can detect reference ARI cases not already found by
alternative parameters. This evaluation was made possible because
EMR-derived parameters were not utilized as independent data
streams. Rather, EMR parameters were related to each other at
the single-patient level.
Amongst a broad field of candidate structured EMR entries, we
found two that could complement ICD-9 codes to detect patients
with ARI: new prescriptions directed at the symptom of cough and
an elevation in measured body temperature recorded in an EMR
field dedicated to vital signs. With 88% of ARI patients
experiencing a new onset of cough, it is not surprising that
prescriptions for cough remedies uncovered new ARI cases. While
these results lend further support to the use of medications-related
data elements for biosurveillance [29,30,31], the practical difficulty
is to devise database queries that, over time, will continue to reflect
the concept of ‘‘cough remedies’’. Cough suppressants belong to a
variety of drug classes (opioids, non-opioid antitussives, deconges-
tants, antihistamines) that are often variably combined with each
other and with other agents to relieve flu-like symptoms. Efforts to
standardize competing drug terminologies and to develop methods
to automatically update medication groupings [27,28] must be
encouraged if symptom-relief medications are to be routinely
incorporated into surveillance systems.
Though significant statistically, the added contribution of the
non-ICD-9 structured EMR parameters to ARI detection was
admittedly modest. We attribute this low marginal utility at least in
part to the mildness of the disease in the majority of our ARI
patients. To wit, providers did not order any blood tests or chest
imaging in 73% of these encounters. Our efforts at devising CDAs
that target the subset of ARI patients with ILI hint at how fruitful
incorporating structured non-ICD-9 EMR parameters may
become as disease severity increases. For example, a parsimonious
ILI CDA (VA ICD-9 codes AND Temperature .37.8uC, CDA
19) increased PPV by an order of magnitude with little losses in
sensitivity compared to its ICD-9 codes-only counterpart. While
we acknowledge that an ICD-9 code set optimized for ILI could
narrow this performance gap, our observations that more
diagnostic tests are ordered with increasing vital signs abnormal-
ities (Fig. 1) raise the prospect that as disease severity increases, so
will the value of the structured EMR data.
In contrast to the potential utility of the ‘‘cough remedies’’ and
the ‘‘Temperature’’ parameters, specific tests and therapies
targeting viral ARI were not utilized, and thus did not contribute
detection value. Perhaps the simplest explanation for why
providers didn’t order tests for viral respiratory pathogens or
anti-influenza drugs is that neither were felt to offer a meaningful
therapeutic impact in non-hospitalized patients during our study
period. Because these practice patterns could change quickly with
the emergence or fear of a more severe illness, and for the
important situational and logistical insight they may provide
during an epidemic, we would certainly retain disease-specific
diagnostic and therapeutic EMR entries in ARI CDAs meant for
an operational surveillance system.
Contribution Of Text Analysis
For surveillance purposes, text analyses have been applied
to limited data sources within the EMR, including ‘‘chief com-
plaint’’ fields [34,35,36,37,38], laboratory or imaging reports
[34,35,38,39,40] or dictated hospital discharge summaries [41,42].
We are aware of only one published study where ARI surveillance
was performed by applying text analysis to the full outpatient notes
typed in by the providers themselves [43]. This study illustrated
the feasibility of using the full narrative text for surveillance in the
ambulatory setting, and showed a temporal correlation between
total daily ILI counts obtained using text analysis, queries of
structured EMR data, categories of chief complaints or influenza
isolates. Our work extends this knowledge in two significant ways.
First, our reference review allowed us to provide insight into the
performance of free-text mining per se. Despite ongoing challenges
with non-standard grammar and abbreviations, spelling mistakes,
lack of punctuation, copy-and-pasting, personal templates and
checklists, our simple approach to free-text analysis discovered
ARI cases with a sensitivity (88%) and a specificity (93%, CDA 10)
not dissimilar to what could be reached with structured parameters
(e.g. CDA 8). Second, the relational nature of EMR data allowed
us to observe the extent to which free-text and structured data
sources could complement each other for case detection. On the
one hand, we found that combining the results of the two mining
approaches through an ‘‘OR’’ logical operand yielded near-perfect
sensitivity, albeit at the cost of a much reduced PPV. These results
support the common-sense belief that, at least with a disease
characterized by relatively mild symptoms, significant information
resides exclusively in the provider’s note. On the other hand, we
found that combining the two approaches through an ‘‘AND’’
logical operand could increase PPVs well above 50% while
retaining sensitivities in the 70% range (CDAs 15, 16, 22). These
results suggest that cross-validating information obtained from
structured data with that obtained from clinical narrative can
reduce false-positive findings from either data sources and improve
the noise environment through which a surveillance system
must operate to uncover disease clusters. Whether or not the
achievable gains in signal-to-noise ratio will outweigh the losses in
detection sensitivity to improve the overall ability of the
surveillance system to detect disease outbreaks will have to be
determined empirically.
Limitations
Several factors, some of which have already been mentioned,
may limit the generalizability of our results: 1) factors related to the
performance of our study at the VA health care system: a) the
veterans study population is mostly male and excludes the
pediatric population, a key target for ARI surveillance [44]; b)
veterans health care utilization may differ from that observed in
uninsured or privately insured individuals; c) clinical practices,
documentation and coding habits by VA practitioners may differ
from those observed in solo or group practices or in health systems
subject to different financial or quality-control incentives; 2) factors
related to our study period: optimal CDAs could differ outside the
respiratory infection season, or during periods of heightened
apprehension for an influenza epidemic; 3) factors related to our
iterative CDA development process, which may have over adapted
CDAs to VA’s particular EMR implementation and to our sample
dataset in particular, this despite our efforts to maintain a
separation between development and validation data subsets; 4)
factors related to our text mining approach: a) we did not employ a
spell checker prior to applying the NegEx algorithm. Instead, we
added common misspellings of negation and search terms (e.g.
‘‘deneis’’ instead of ‘‘denies’’, ‘‘cocuphing’’ instead of ‘‘coughing’’)
Biosurveillance Using EMR Data
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misspellings are left out of our final UMLS concept table and
negation list; b) our adaptation of the NegEx algorithm is specific
to the types of EMR note from only two VA medical centers.
Further adaptations could therefore be needed for text documents
extracted from the VISTA systems at other VA facilities.
Summary
Our results confirms that it is feasible to harness the EMR for
biosurveillance purposes and that judicious parameter selection
coupled with free-text analyses can yield case-detection tools with
performance characteristics not previously available through
diagnostic codes only. Much more work remains to be done both
to replicate our results under different health delivery environ-
ments and to determine which case-detection strategy shortens
outbreak detection delay and/or minimizes the burden that false
alarms impose on public health professionals.
Materials and Methods
Ethics Statement
This study was approved by the Institutional Review Boards
(IRBs) of the participating VA health systems and those of the
University of Maryland, the University of Utah and the Johns
Hopkins University. The risks were limited to information
confidentiality involving data generated during the course of
routine patient care. The study did not interfere with such care
and thus did not adversely affects the rights and welfare of the
participants. The IRBs granted a waiver of consent on that basis
and because, given the large number of participants, the work
would not have been practicable otherwise. The data collected are
specified in the ‘‘Description of Procedures’’ section below.
Participants
We randomly sampled outpatient clinical encounters from
October 1, 2003 through March 31, 2004 at VA Maryland
(VAMHCS) and at VA Salt Lake City (VASLCHCS) Health Care
systems. While we aimed at sampling as broad an outpatient visit
population as possible, it was nevertheless not useful to include
specialized areas of care that neither diagnose nor treat ARI, such
as psychiatry or ophthalmology. We therefore limited our
sampling to outpatient care areas where at least two encounters
were assigned ICD-9 codes related to ARI (see below) during the
study period. Individual patients were sampled only once.
Description of Procedures and Statistical Methods
Reference record review. A manual review of EMR entries
constituted the reference standard for ARI case detection. The
unit of analysis was the calendar day of an index outpatient
encounter. A trained abstractor reviewed all EMR entries during
the calendar day of each index encounter for documentation
indicative of ARI. Predefined ARI symptoms and signs were
recorded individually on an abstraction instrument (MS Access,
Microsoft Corp., Redmond WA). ARI was defined as follows: [1)
Positive influenza culture/antigen; OR 2) Any two of the
following, of no more than 7 days duration: a) cough; b) fever or
chills or night sweats; c) pleuritic chest pain; d) myalgia; e) sore
throat; f) headache] AND [3) Illness not attributable to a non-
infectious etiology]. All uncovered ARI cases and a 10% random
sub-sample of negative records were re-reviewed by a physician,
who validated the ARI-defining elements, and who could also
access any part of the EMR for documentation that would indicate
that a non-infectious disease could best explain the current illness.
A panel of specialists in pulmonary and infectious diseases
arbitrated cases where there was disagreement. Sample size was
adjusted so that we could reach ,140 reference ARI cases at each
study site, a goal estimated by the need to have sufficient power to
perform a regression analysis that included our planned candidate
explanatory variables (EpiInfo, Version 2.2, Centers for Disease
Control and Prevention).
Development of ARI case-detection algorithms (CDA) that
use structured EMR parameters. Practicing clinicians from
the research team systematically reviewed and adjucated structured
or semi-structured EMR parameters that could potentially identify
patients with ARI and that would be available within24 hoursof an
index encounter. The parameters chosen were: a) ICD-9 diagnostic
code(s) included in the existing ‘‘respiratory’’ groupings from SSS of
national scope (either the Centers for Disease Control and
Prevention (CDC) BioSense [45] or the Department of Defense’s
ESSENCE [46] systems)OR the ICD-9 code for fever (780.6). Note
that ICD-9 codes are assigned by VA health care providers when
they complete their clinical note for an outpatient visit in EMR, and
are thus rapidly available for surveillance; b) vital sign abnormalities
(temperature $38uC, respiratory rate $22 breath per minute, heart
rate $100 beats per minute); c) orders for tests (complete blood
count (CBC) with or without differential cell count, influenza
antigen or culture, diagnostic tests for respiratory organisms other
than influenza (respiratory syncytial virus, adenovirus, legionella),
streptococcal throat screen, sputum culture or Gram stain, Gram
stain for other respiratory specimens, blood cultures); d) requests for
diagnostic imaging (chest X-ray, chest computerized tomography,
any respiratory sinus imaging); and e) new prescriptions (none
similar in the last 90 days), selected from the VA national formulary
and grouped into the following parameters by expert consensus:
cough remedies (from VA national formulary (VANF) drug classes
RE-200, -301, -302, -502, -503, -507, -508, -513, -516, or codeine),
‘‘other cold remedies’’ (from VANF CN-900, MS-102, NT-100, -
200, -400, -900, RE-99, -501); antiemetics (from VANF GA-700),
antidiarrheals (from VANF GA-400), influenza-targeting antivirals
(neuraminidase inhibitors or adamantanes), and alternative group-
ings of antibacterials (i: 33 antibiotics that could be prescribed for
ARI (from VANF AM-051, -052, -053, -101, -102, -103, -200, -250,
-300, -650 and -900); ii: 11 antibiotics commonly prescribed for
ARI (clarithromycin, erythromycin, azithromycin, clindamycin,
amoxicillin/clavulanate, amoxicillin, penicillin V, gatifloxacin,
levofloxacin, cefaclor, tetracycline and doxycycline); iii: the three
antibiotics most commonly associated with an encounter ascribed
an ICD-9 code from the ESSENCE ‘‘respiratory’’ grouping at both
sites (amoxicillin/clavulanate, azithromycin and clarithromycin).
All of the data elements required to construct the above EMR
parameters in the study population were transferred from the
Veterans Integrated Service Technology Architecture (VistA)
hierarchical database to a Structured Query Language (SQL)
relational database using the Mumps Data Extractor software
(Strategic Reporting Systems Inc., Peabody, MA). Data elements
were included if they were entered in the EMR within the calendar
day of the index encounters. Subsequent data transformations and
database queries were implemented using SQL Server 2000
(Microsoft Corp., Redmond, WA).
ARI CDAs were developed independently for each study site.
For a given site, the clinician-selected EMR parameters were
reduced to include only those that contributed significantly to
detection of reference ARI cases using backward elimination
logistic regression with 95% confidence intervals [47]. Supple-
mental statistics in those analyses included Akaike’s Information
Criterion, Wald’s Chi Square Test, Likelihood Ratio Test Statistic,
and Drop-In-Deviance. Explanatory parameters were explored for
multicollinearity with variance inflation factors and Spearman
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with standard statistical descriptors (sensitivity, specificity, positive
and negative predictive value, and an estimate of the area under
the Receiver-Operating Characteristic (ROC) curve [48]). Bootstrap
analysis with 95% confidence intervals was conducted to test the
reliability of the most successful ARI CDAs [49]. For a given
CDA, the dataset was divided by placing a random sample of
80% of the data in a first subset, and the remaining 20% in a
second subset. The previous analyses for the selected case
detectors were performed on the 80% subset. The statistical
descriptions for the case detectors in each dataset were compared
and the results were found to be similar to those for the entire
dataset. The case detectors were then used to predict the ARI
cases in the 20% subset. Data for each case detector was
resampled 100 times to ensure consistent results. All statistical
analyses and ROC estimates were performed using Splus (Version
6.1, Insightful Corp., Seattle, WA).
Development of ARI CDAs that use unstructured clinical
text. Of the many free-text data sources within the EMR, we
focused on the notes typed in by providers to document outpatient
visits. Our goal was first to apply simple methods using character
string matching coupled with negation detection to extract
information documenting ARI symptoms. If a clinical note
related to an index visit contained non-negated strings related to
two or more symptoms from our ARI case definition, then the
index visit was labeled as ‘‘positive’’ for the presence of ARI.
To develop a list of search strings, we began by mapping ARI
symptoms from our case definition to the Unified Medical
Language System (UMLS) using the National Library of Medicine
UMLS MetathesaurusH search tool [50]. The UMLS incorporates
many common source vocabularies (including ICD-9, MeSH, and
SNOMED) and maps concepts to a standard vocabulary
represented by concept unique identifier (CUI) codes
[41,50,51,52,53,54]. We examined all of the UMLS-supplied
lexical variants and semantic types related to ARI [50] to build the
final list of strings. This list included 186 synonyms, term variants,
and common misspellings (Table S1).
We searched for the text strings identified above in the full text
of all EMR clinical notes completed on the calendar day and
related to each index encounter (76,500 notes related to 15,377
encounters). To determine if concepts identified by the text strings
were affirmed or negated, for example whether a patient was
‘‘coughing’’ or denied ‘‘coughing’’, we used the publicly available
NegEx version 2 algorithm [55]. We sought to improve the
performance of the native algorithm by iteratively reviewing 10-
15% of notes associated with false negative and false positive cases,
then correcting problems with negation detection. Reusable text
templates and checklists, commonly imported into VA note
documents, drove most of the modifications to the NegEx
algorithm, which included: 1) adding pre-processing steps to
remove extraneous white spaces, carriage returns and line feeds; 2)
identifying special characters commonly associated with imported
templates (e.g. series of ----------------, ********** to indicate section
breaks) or indicating embedded data-mining software objects used
to automatically retrieve vital signs or medication lists; 3)
identifying headings of templates that often contained a list of
non-negated ARI-related strings (e.g. ‘‘Cough Assessment’’,
‘‘Clinician Instructions’’, ‘‘Problems to Report to Your Doctor’’,
‘‘Needed For’’, ‘‘Observe For’’); 4) modifying the term list used by
NegEx for possible negation status (e.g. adding the term ‘‘absent’’);
5) using regular expressions to identify non-textual patterns where
the concept identified was either affirmed or negated by special
characters or abbreviations (e.g. neg, pos, [n] cough, [p] fevers,
(+/-), [n/a], &, /, or *); 6) expanding the negation window up to
the next full stop or to the end of a section (indicated by: [ ], (), (n),
(-), or a dot).
Supporting Information
Table S1 ARI Concepts, Synonyms, and Concept Unique
Identifier (CUI) codes.
Found at: doi:10.1371/journal.pone.0013377.s001 (0.19 MB
DOC)
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